Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Quality Improvement Initiative: Improving Time to First Dose in a Sickle Cell Infusion Center

Foluso Joy Ogunsile, MD, Julia Z. Xu, MD MSc, Elizabeth Brown, Elizabeth Williams, BA, Sophie M. Lanzkron, MD

Blood (2019) 134 (Supplement_1): 3404.

https://doi.org/10.1182/blood-2019-131970

Published: 2019

Journal Articles

Chronic Kidney Disease Is Under-Screened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell Registry

Elizabeth Williams, BA, Elizabeth Brown, Deepa Manwani, MD, Payal Desai, MD, Joshua J. Field, MD, Lynne D. Neumayr, Susan Padrino, MD, E. Leila Jerome Clay, MD MCTS, FAAP, Ze Cong, PhD, Irene Agodoa, MD, Carolyn Hoppe, MD, Sophie M. Lanzkron, MD, Jane A. Little, MD

Blood (2019) 134 (Supplement_1): 2284.

https://doi.org/10.1182/blood-2019-124933

Published: 2019

Journal Articles

Trends in Hydroxyurea Utilization for the Treatment of Sickle Cell Anemia in Florida

Vandy Black, MDMSc, Jasmine A Mack, MPH, Jaclyn Hall, PhD, Heather Morris, PharmD, BCPS, Elizabeth Shenkman, PhD, Matthew J Gurka, PhD

Blood (2019) 134 (Supplement_1): 2293.

https://doi.org/10.1182/blood-2019-125799

Published: 2019

Journal Articles

Standard Definitions of Pneumococcal Immunity May Not Accurately Predict Protection in Adults with Sickle Cell Disease

Tara M. Robinson, MD PhD, Sophie M. Lanzkron, MD

Blood (2019) 134 (Supplement_1): 1014.

https://doi.org/10.1182/blood-2019-126056

Published: 2019

Journal Articles

Neurodevelopmental Disorders in Pediatric Sickle Cell Disease

Eboni I. Lance, MD, Alicia D. Cannon, PhD, Bruce K. Shapiro, MD, Michael V. Johnston, MD, James F. Casella, MD

Blood (2019) 134 (Supplement_1): 1016.

https://doi.org/10.1182/blood-2019-121968

Published: 2019

Journal Articles

Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell Disease

Anna M Hood, PhD, Yolanda Johnson, MLS, Cara Nwankwo, BA, Lisa M Shook, MA, Aimee K Hildenbrand, PhD, Allison A. King, MD MPH, PhD, Kim Smith-Whitley, MD, Sherif M. Badawy, MD, Alexis A Thompson, MD MPH, Susan E Creary, MD, Connie M. Piccone, MD, Lynne D. Neumayr, Jean L. Raphael, MD MPH, Amber M Yates, MD, Sohail Rana, MD, Steven K Reader, PhD, Emily Riehm Meier, MD MSHS, Amy Sobota, MD MPH, Lori E. Crosby, PhD

Blood (2019) 134 (Supplement_1): 4713.

https://doi.org/10.1182/blood-2019-124835

Published: 2019

Journal Articles

Anti-Mullerian Hormone, a Measure of Ovarian Reserve, Is Low in Female Subjects in the Multi-Center Study of Hydroxyurea

Lydia H. Pecker, MD, Eli Salzberg, Shruti Chaturvedi, MBBS, MS, Ni Zhao, MD PhD, Mindy S Christianson, MD MBA, Sophie M. Lanzkron, MD

Blood (2019) 134 (Supplement_1): 890.

https://doi.org/10.1182/blood-2019-122137

Published: 2019

Journal Articles

Patient Perception on Health Care Delivery for Sickle Cell Disease and Opportunities for Quality Improvement

Ofelia A. Alvarez, MD, Sandra Echenique, Hector Rodriguez-Cortes, MD, Thomas J. Harrington, MD, E. Leila Jerome Clay, MD MCTS, FAAP, Vandy Black, MDMSc, Mary Murph, Christopher Wells, Ifeyinwa (ify) Osunkwo, MDMPH

Blood (2019) 134 (Supplement_1): 5862.

https://doi.org/10.1182/blood-2019-123215

Published: 2019

Journal Articles

Economic Burden of End Organ Damage Among Patients with Sickle Cell Disease in the US

Xue Song, Andrew D. Campbell, MD, Ze Cong, PhD, Irene Agodoa, MD, Diane Martinez, DrPH, MPH, Carolyn R. Lew, PhD, Danae Black, Helen Varker, Chris Chan, Sophie M. Lanzkron, MD

Blood (2019) 134 (Supplement_1): 3388.

https://doi.org/10.1182/blood-2019-127173

Published: 2019

Journal Articles

Characterizing the Use of Direct Oral Anticoagulants in Children Using the American Thrombosis and Hemostasis Network Dataset (ATHNdataset)

Jennifer G. Davila, MD, Dunlei Cheng, PhD, Leslie J. Raffini, MD, Courtney D. Thornburg, MD, Fernando F. Corrales-Medina, MD

Blood (2019) 134 (Supplement_1): 1156.

https://doi.org/10.1182/blood-2019-128324

Published: 2019

Journal Articles

Societal Costs of Sickle Cell Disease in the United States

Irene Agodoa, MD, Deborah Lubeck, PhD, Nickhill Bhakta, MD MPH, Mark Danese, MHS, PhD, Kartik Pappu, PhD, Robin Howard, MBA, Michelle Gleeson, PhD, Marc Halperin, BA, Sophie Lanzkron, MD MHS

Blood (2018) 132 (Supplement 1): 4706.

https://doi.org/10.1182/blood-2018-99-119420

Published: 2018

Journal Articles

Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine

Mandy David, PA-C, MPH, Christopher Carroll, MD, Ashley Lauriello, NP, Benjamin Salzberg, Sophie Lanzkron, MD MHS

Blood (2018) 132 (Supplement 1): 856.

https://doi.org/10.1182/blood-2018-99-111435

Published: 2018

Journal Articles

Administration of BPX-501 Cells Following Aβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias

Franco Locatelli, Annalisa Ruggeri, MD PhD, Pietro Merli, MD, Swati Naik, MBBS, Rajni Agarwal, MD, Victor Aquino, MD, David A. Jacobsohn, MD, Waseem Qasim, MD PhD, Eneida R. Nemecek, MD, Lakshmanan Krishnamurti, MD, Deepa Manwani, MD, Melissa Kuhn, PharmD, Neena Kapoor

Blood (2018) 132 (Supplement 1): 307.

https://doi.org/10.1182/blood-2018-99-119481

Published: 2018

Journal Articles

Developmental Outcomes of Children Exposed to Maternal Sickle Cell Disease (SCD)

Martha Brucato, PhD, Xiaobin Wang, MD ScD, Sophie Lanzkron, MD

Blood (2017) 130 (Supplement 1): 983.

https://doi.org/10.1182/blood.V130.Suppl_1.983.983

Published: 2017

Journal Articles

Adult Hemophagocytic Lymphohistiocytosis-a Quality Improvement Initiative

Samuel A. Merrill, MD PhD, Rakhi P. Naik, MD, Evan M Braunstein, MDPhD, Michael B. Streiff, Satish Shanbhag, MD, Sophie Lanzkron, MD, Alison R. Moliterno, MD, Robert A. Brodsky, MD

Blood (2017) 130 (Supplement 1): 677.

https://doi.org/10.1182/blood.V130.Suppl_1.677.221

Published: 2017

Journal Articles

Men with Sickle Cell Disease Show Significant Concerns over Safety While Being Treated for Vaso-Occlusive Crises: Preliminary Observations from the Escaped Trial

Blood (2017) 130 (Supplement 1): 129.

https://doi.org/10.1182/blood.V130.Suppl_1.129.129

Published: 2017

Journal Articles

Physician Prescribing Practices in Sickle Cell Disease

Foluso Joy Ogunsile, MD, Zhuo Tony Su, BSc, Sophie Lanzkron, MD, Jodi Segal

Blood (2017) 130 (Supplement 1): 3540.

https://doi.org/10.1182/blood.V130.Suppl_1.3540.3540

Published: 2017

Journal Articles

A Prospective Multi-Centered Registry Is Feasible in Sickle Cell Disease: Globin Regional Network for Data and Discovery (GRNDaD)

Matthew Sears, Caroline Ewing, Sophie Lanzkron, MD, Joshua J. Field, MD, Carolyn C Hoppe, MD, Jane A. Little, MD

Blood (2017) 130 (Supplement 1): 3375.

https://doi.org/10.1182/blood.V130.Suppl_1.3375.3375

Published: 2017

Journal Articles

Quantification of Whole-Brain Oxygenation Extraction Fraction Among People with Sickle Cell Anemia without Stroke History

Wenbo Li, PhD, Xiang Xu, PhD, Peiying Liu, PhD, Emily Jacobs, B.S., John J. Strouse, MD PhD, James F. Casella, MD, Hanzhang Lu, PhD, Peter van Zijl, PhD, Qin Qin, PhD

Blood (2017) 130 (Supplement 1): 3524.

https://doi.org/10.1182/blood.V130.Suppl_1.3524.3524

Published: 2017

Journal Articles

Suppression of the Hemodynamic Response Function Demonstrates Altered Cerebral Vasoreactivity in Sickle Cell Disease

Melanie E. Fields, MD MSCI, Rebecca Coalson, Liam Comiskey, Mario Ortega, PhD, Dustin K. Ragan, PhD, Allison King, MD MPH, PhD, Joshua Shimony, MD PhD, Andria L. Ford, MD MSCI, Jin-Moo Lee, MD PhD, Nico Dosenbach, MD PhD

Blood (2016) 128 (22): 12.

https://doi.org/10.1182/blood.V128.22.12.12

Published: 2016

NARROW

Quality Improvement Initiative: Improving Time to First Dose in a Sickle Cell Infusion Center

Chronic Kidney Disease Is Under-Screened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell Registry

Trends in Hydroxyurea Utilization for the Treatment of Sickle Cell Anemia in Florida

Standard Definitions of Pneumococcal Immunity May Not Accurately Predict Protection in Adults with Sickle Cell Disease

Neurodevelopmental Disorders in Pediatric Sickle Cell Disease

Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell Disease

Anti-Mullerian Hormone, a Measure of Ovarian Reserve, Is Low in Female Subjects in the Multi-Center Study of Hydroxyurea

Patient Perception on Health Care Delivery for Sickle Cell Disease and Opportunities for Quality Improvement

Economic Burden of End Organ Damage Among Patients with Sickle Cell Disease in the US

Characterizing the Use of Direct Oral Anticoagulants in Children Using the American Thrombosis and Hemostasis Network Dataset (ATHNdataset)

Societal Costs of Sickle Cell Disease in the United States

Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine

Administration of BPX-501 Cells Following Aβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias

Developmental Outcomes of Children Exposed to Maternal Sickle Cell Disease (SCD)

Adult Hemophagocytic Lymphohistiocytosis-a Quality Improvement Initiative

Men with Sickle Cell Disease Show Significant Concerns over Safety While Being Treated for Vaso-Occlusive Crises: Preliminary Observations from the Escaped Trial

Physician Prescribing Practices in Sickle Cell Disease

A Prospective Multi-Centered Registry Is Feasible in Sickle Cell Disease: Globin Regional Network for Data and Discovery (GRNDaD)

Quantification of Whole-Brain Oxygenation Extraction Fraction Among People with Sickle Cell Anemia without Stroke History

Suppression of the Hemodynamic Response Function Demonstrates Altered Cerebral Vasoreactivity in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only